Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery for Cholecystectomy

Sponsor
Jose F. Noguera (Other)
Overall Status
Completed
CT.gov ID
NCT01558414
Collaborator
Hospital Mateo Orfila (Other)
60
1
3
19.1
3.1

Study Details

Study Description

Brief Summary

Prospective randomized pilot clinical trial, with 3 arms and one year follow up. The study will include 60 patients, with a 1:1:1 ratio, 20 patients per group. In 40 patients a transumbilical single site incision will be performed with two different manners: single-port device SILS TM (Single Incision Laparoscopic Surgery), and flexible endoscope and accessory trocars in a single incision (FSIS-Flexible Single Incision Surgery). The third group is the control one, a conventional laparoscopic approach.

The trial is designed as a pilot study to assess, as main objective, if these two endoscopic approaches have the same security and effectiveness in cholecystectomy.

Hypothesis:

Transumbilical approaches with single port and single incision with the flexible endoscope have the same efficacy and safety performing the endoscopic cholecystectomy.

Objectives:
Main objective:

Assess whether both approaches are equally safe in its application to endoscopic cholecystectomy.

Secondary objectives:

Investigate the differences in the rate of conversion to open surgery between different surgical approaches.

Investigate the differences in the rate of wound infection between the different surgical approaches.

Investigate the differences in the rate of postoperative incisional hernias between different surgical approaches.

Investigate whether there are differences in the rate of overall complications, all-cause mortality and the cost between different surgical approaches.

Condition or Disease Intervention/Treatment Phase
  • Procedure: SILS Cholecystectomy
  • Procedure: FSIS cholecystectomy
  • Procedure: Conventional laparoscopy
Phase 3

Detailed Description

Inclusion criteria:
  • Patients affected with symptomatic cholelithiasis with elective surgical indication, not urgent, aged between 18 and 65.

  • Signing of informed consent for cholecystectomy and specific consent for the trial.

  • Anesthetic risk ASA I-II.

Exclusion criteria:
  • Presence of acute cholecystitis and / or suspicion of occupation of the main bile duct.

  • ASA III and higher.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Randomized Clinical Trial Comparing Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery on Cholecystectomy
Study Start Date :
Apr 1, 2011
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: SILS

Cholecystectomy performed by Single Incision Laparoscopic Surgery with the SILS TM device

Procedure: SILS Cholecystectomy
Cholecystectomy performed by Single Incision Laparoscopic Surgery with the SILS TM device

Experimental: FSIS

Cholecystectomy performed by Flexible Single Incision Surgery with the flexible endoscope through a single incision at the umbilicus

Procedure: FSIS cholecystectomy
Cholecystectomy performed by Flexible Single Incision Surgery with the flexible endoscope through a single incision at the umbilicus

Active Comparator: Conventional laparoscopy

Cholecystectomy performed by a conventional laparoscopic approach

Procedure: Conventional laparoscopy
Minimally invasive cholecystectomy through the conventional laparoscopic approach using 3 ports (one 11-cm umbilical port and two accessory 5-mm ports).

Outcome Measures

Primary Outcome Measures

  1. Surgical safety [During surgical intervention]

    Number of patients without clinical problems in the surgery

Secondary Outcome Measures

  1. Conversion to other surgical approach [During the surgical intervention]

    Rate of conversion to conventional laparoscopic surgery and open surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age over 18 and under 65

  • symptomatic cholelithiasis with an indication for laparoscopic surgery

  • signed specific informed consent including specific information of the new surgical approach

  • ASA 1 and 2.

Exclusion Criteria:
  • current or previous cholecystitis

  • current or previous suspected bile duct's problems

  • previous abdominal surgery

  • umbilical and other abdominal hernias

  • some other condition with increased risk to infection or abdominal wall problems.

  • ASA 3 and more

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Son Llàtzer Palma de Mallorca Illes Balears Spain 07198

Sponsors and Collaborators

  • Jose F. Noguera
  • Hospital Mateo Orfila

Investigators

  • Study Director: José F Noguera, MD, PhD, Hospital Son Llàtzer
  • Study Chair: Juan C García, MD, Hospital Son Llàtzer

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jose F. Noguera, Chief Department of Surgery, Hospital Son Llatzer
ClinicalTrials.gov Identifier:
NCT01558414
Other Study ID Numbers:
  • Llatzer-FSIS
First Posted:
Mar 20, 2012
Last Update Posted:
Mar 12, 2013
Last Verified:
Mar 1, 2013
Keywords provided by Jose F. Noguera, Chief Department of Surgery, Hospital Son Llatzer
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 12, 2013